Novartis Stopping Work on Branaplam as Oral SMA Therapy & 31 Days of SMA

Novartis Stopping Work on Branaplam as Oral SMA Therapy & 31 Days of SMA

SMA News Today’s multimedia associate, Price Wooldridge, discusses Novartis stopping work on the development of Branaplam as an oral treatment for Spinal Muscular Atrophy (SMA). Forums Director Kevin Schaefer reads a story from our 31 Days of SMA series. This piece, written by Alvaro Cheherlian, is about being an entrepreneur with SMA. Link to 31 Days of SMA series: https://smanewstoday.com/category/31-days-of-sma/ Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/

Avsnitt(444)

Populärt inom Hälsa

somna-med-henrik
rss-bara-en-till-om-missbruk-medberoende-2
rss-jossan-nina
inga-beiga-morsor
rss-vuxna-pa-latsas
johannes-hansen-podcast
not-fanny-anymore
angestpodden
sexnoveller-deluxe
rss-viktmedicinpodden
alska-oss
brottarbroder
sova-med-dan-horning
sa-in-i-sjalen
tyngre-radio
rss-sjalsligt-avkladd
tyngre-traningssnack
rss-basta-livet
rss-livet-pagar-din-coachningpodcast
smartare-fitness-podden